Kurt Højlund

Search results

• Effects of a six-month low-carbohydrate diet in patients with type 2 diabetes on glycemic control, body composition and cardiovascular risk factors

  Gram-Kampmann, E. (Author), Dalby Hansen, C. (Co-author), Balle Hugger, M. (Co-author), Møller Jensen, J. (Co-author), Brønd, J. C. (Co-author), Hermann, A. P. (Co-author), Olsen, M. H. (Co-author), Krag, A. (Co-author), Beck-Nielsen, H. (Co-author) & Højlund, K. (Co-author)

  21. Sept 2020 → 25. Sept 2020

  Activity: Talks and presentations › Conference presentations

• Effects of a six-month low-carbohydrate diet in patients with type 2 diabetes on glycemic control, body composition and cardiovascular risk factors

  Gram-Kampmann, E. (Speaker), Dalby Hansen, C. (Co-author), Olsen, M. H. (Co-author), Krag, A. (Co-author), Beck-Nielsen, H. (Co-author) & Højlund, K. (Co-author)

  17. Jan 2020 → 18. Jan 2020

  Activity: Talks and presentations › Conference presentations

  File

• BONE, ENERGY METABOLISM AND DIABETES: INTEGRATED PHYSIOLOGY AND CLINICAL APPLICATIONS

  Morten Frost Munk Nielsen (Organizer), Kurt Højlund (Organizer), Michaela Tencerova (Organizer) & Moustapha Kassem (Organizer)

  3. Oct 2016 → 4. Oct 2016

  Activity: Attending an event › Organisation or participation in workshops, courses or seminars

• Lifestyle impact on mitochondrial biogenesis.

  Kurt Højlund (Lecturer)

  3. Oct 2012

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Effect of hyperglycaemia on whole-body glucose metabolism and muscle glycogen synthase activity during physiological hyperinsulinaemia in type 2 diabetes

  Kurt Højlund (Speaker)

  30. Sept 2009 → 2. Oct 2009

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Phosphoproteomic and transcriptomic characterization of mitochondrial dysfunction in insulin resistant muscle

  Kurt Højlund (Lecturer)

  14. Nov 2008

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Estimates of the bioactivity of IGF-II in serum from healthy subjects, obese subjects and obese type 2 diabetic patients

  Kurt Højlund (Speaker)

  16. Sept 2008 → 20. Sept 2008

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Circulating levels of Insulin-like Growth Factor-II Receptor in type 1 and type 2 diabetic patients

  Kurt Højlund (Speaker)

  9. May 2008 → 11. May 2008

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Genetic Variants and Phenotypic Characteristics of Patients with Type 2 Diabetes Mellitus (T2DM)

  Kurt Højlund (Speaker)

  9. May 2008 → 11. May 2008

  Activity: Talks and presentations › Talks and presentations in private or public companies

• The effect of endurance training on insulin-mediated glucose metabolism and markers of muscle glucose storage in obesity and type 2 diabetes

  Højlund, K. (Speaker)

  9. May 2008 → 11. May 2008

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Mitochondrial dysfunction in skeletal muscle insulin resistance. Application of transcriptomics and proteomics

  Højlund, K. (Lecturer)

  10. Apr 2008

  Activity: Talks and presentations › Talks and presentations in private or public companies

• A role for CaMKII in impaired insulin activation of glycogen synthase activity in skeletal muscle of patients with type 2 diabetes.

  Kurt Højlund (Speaker)

  26. Jan 2008 → 27. Jan 2008

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Identification of multiple phosphorylation sites on ATP synthase beta subunit in human muscle. Increased phosphorylation at Thr213 and Tyr361 in obesity and type 2 diabetes

  Kurt Højlund (Speaker)

  2008

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment

  Kurt Højlund (Lecturer)

  13. May 2007

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Hypoglycemia & Insulin resistance. A novel Syndrome.

  Kurt Højlund (Lecturer)

  11. May 2007

  Activity: Talks and presentations › Talks and presentations in private or public companies